cellular
• G:C->A:T transversions are increased in frequency compared to Nudt-null mice
|
Allele Symbol Allele Name Allele ID |
Nudt1tm1Tts targeted mutation 1, Teruhisa Tsuzuki MGI:2387695 |
||||||||||||||||||||||||||||||||
Summary |
7 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• G:C->A:T transversions are increased in frequency compared to Nudt-null mice
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• lesions of the glandular stomach are 3 times as frequent as in controls
• adenomatous hyperplasia, adenomas, and adenocarcinoma
|
• liver tumors in 38% of males as opposed to 13% of control males
• liver tumors in 3.9% of females as opposed to none in female controls
|
• found in greater numbers at age 1.5 years
|
• found in greater numbers at age 1.5 years
|
• lesions of the glandular stomach are 3 times as frequent as in controls
• adenomatous hyperplasia, adenomas, and adenocarcinoma
|
• found in greater numbers at age 1.5 years
|
• found in greater numbers at age 1.5 years
|
• liver tumors in 38% of males as opposed to 13% of control males
• liver tumors in 3.9% of females as opposed to none in female controls
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• 3-NP-treated mice exhibit normal distance traveled in an open-field test
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• mice are highly susceptible to spontaneous tumorigenesis within 100 days of birth
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• spleen cells show a significant increase in frameshift mutations at mononucleotide runs relative to wild-type when assayed with a reporter system
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• striatal degeneration in 3-NP-treated mice
• however, calpain and PARP inhibitors suppress striatal neurodegeneration and behavioral impairments
|
• in 3-NP-treated mice, especially in the dorsal striatum
|
• striatal degeneration in 3-NP-treated mice
• however, calpain and PARP inhibitors suppress striatal neurodegeneration and behavioral impairments
|
• 3-NP treated mice exhibit increased motor impairment (neurological score based on: general slowness of displacement resulting from mild hindlimb impairment;, incoordination and marked gait abnormality; hindlimb paralysis; incapacity to move resulting from forelimb and hindlimb impairment) compared with wild-type mice
|
• in 3-NP-treated mice
|
• 3-NP-treated mice travel less distance in an open-field test compared with wild-type mice that is more severe than in Ogg1tm1Skmi homozygotes
• 3-NP-treated mice are hypoactive in home cages compared with wild-type mice
• however, calpain and PARP inhibitors suppress striatal neurodegeneration and behavioral impairments
|
• striatal degeneration in 3-NP-treated mice
• however, calpain and PARP inhibitors suppress striatal neurodegeneration and behavioral impairments
|
• 3-NP treated mice exhibit an accumulation of 8-oxoG that results in the accumulation of single strand breaks in mitochondrial DNA of striatal medium spiny neurons and nuclear DNA of striatal microglia compared with wild-type mice
|
• striatal degeneration in 3-NP-treated mice
• however, calpain and PARP inhibitors suppress striatal neurodegeneration and behavioral impairments
|
• 3-NP treated mice exhibit an accumulation of 8-oxoG that results in the accumulation of single strand breaks in mitochondrial DNA of striatal medium spiny neurons and nuclear DNA of striatal microglia compared with wild-type mice
|
• in 3-NP-treated mice, especially in the dorsal striatum
|
• in 3-NP-treated mice, especially in the dorsal striatum
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|